Inscripta Inc. raised $125 million in its series D funding round, which was led by Paladin Capital Group.
New investors JS Capital Management LLC and Oak HC/FT Partners LLC participated in the round, alongside existing investors.
Inscripta has now raised a total of $259.5 million.
Inscripta is a Boulder, Colo.-based biotechnology company that is developing a benchtop platform for genome-scale engineering.